Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.54 |
| ▸ | L3MBTL3 | Q96JM7 | 9/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 8/20 | 0.47 |
| ▸ | MBTD1 | Q05BQ5 | 5/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.37 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.36 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6395460 | 1.00 | HTR6 (0.54) | HTR6L3MBTL3L3MBTL1MBTD1HPGD | |
| Hydrochloric Acid SCHEMBL6952706 | 0.97 | HTR6 (0.52) | HTR6L3MBTL3L3MBTL1MBTD1HPGD | |
| SCHEMBL2233012 | 0.97 | HTR6 (0.52) | HTR6L3MBTL3L3MBTL1MBTD1HPGD | |
| Ammonia Solution, Strong SCHEMBL19410104 | 0.97 | HTR6 (0.52) | HTR6L3MBTL3L3MBTL1MBTD1HPGD | |
| Hydrochloric Acid SCHEMBL15232249 | 0.97 | HTR6 (0.52) | HTR6L3MBTL3L3MBTL1MBTD1HPGD | |
| [1,4']Bipiperidinyl SCHEMBL352141 | 0.97 | HTR6 (0.52) | HTR6L3MBTL3L3MBTL1MBTD1HPGD | |
| SCHEMBL3159634 | 0.97 | HTR6 (0.52) | HTR6L3MBTL3L3MBTL1MBTD1HPGD | |
| [1,4']Bipiperidinyl SCHEMBL42685 | 0.97 | HTR6 (0.52) | HTR6L3MBTL3L3MBTL1MBTD1HPGD | |
| [1,4']Bipiperidinyl SCHEMBL2250608 | 0.95 | HTR6 (0.50) | HTR6L3MBTL3L3MBTL1MBTD1HPGD | |
| [1,4']Bipiperidinyl SCHEMBL19410113 | 0.95 | HTR6 (0.50) | HTR6L3MBTL3L3MBTL1MBTD1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2280 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3894447-B1 | STABILISERS FOR USE IN INVERSE EMULSION POLYMERISATION PROCESSES | SOLENIS TECHNOLOGIES CAYMAN LP (KY) | 2025-08-13 | — | — | EP | claimed |
| US-12234303-B2 | Stabilisers for use in inverse emulsion polymerisation processes | SOLENIS TECHNOLOGIES, L.P. (US) | 2025-02-25 | — | — | US | claimed |
| US-12195446-B2 | Heteroaryl compounds and their use as therapeutic drugs | DONG-A SOCIO HOLDINGS CO., LTD. (KR) | 2025-01-14 | — | — | US | claimed |
| CN-119039178-A | Preparation method of alpha-cyanoacrylate and medical adhesive | 深圳聚环科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-117624140-A | CXCR4 antagonists, methods of making and uses thereof | 杭州师范大学 | 2024-03-01 | — | — | CN | claimed |
| US-20230002353-A1 | HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS | DONG A SOCIO HOLDINGS CO LTD (KR) | 2023-01-05 | — | — | US | claimed |
| CN-112898170-B | Preparation method of acid diffusion inhibitor and photoresist composition | 宁波南大光电材料有限公司 | 2022-10-04 | — | — | CN | claimed |
| US-20220049028-A1 | STABILISERS FOR USE IN INVERSE EMULSION POLYMERISATION PROCESSES | SOLENIS TECHNOLOGIES CAYMAN, L.P. (KY) | 2022-02-17 | — | — | US | claimed |
| EP-3894447-A1 | STABILISERS FOR USE IN INVERSE EMULSION POLYMERISATION PROCESSES | Solenis Technologies Cayman, L.P. (KY) | 2021-10-20 | — | — | EP | claimed |
| CN-113412283-A | Stabilizers for inverse emulsion polymerization processes | 索理思科技开曼公司 | 2021-09-17 | — | — | CN | claimed |
| WO-2007100851-A1 | THERAPEUTIC COMPOUNDS | HELICON THERAPEUTICS, INC. (US) | 2007-09-07 | — | — | WO | claimed |
| US-20070203154-A1 | Therapeutic Compounds | DART NEUROSCIENCE (CAYMAN) LTD. (KY) | 2007-08-30 | — | — | US | claimed |
| EP-1794161-A2 | MUSCARINIC RECEPTOR ANTAGONISTS | Ranbaxy Laboratories Limited (IN) | 2007-06-13 | — | — | EP | claimed |
| CN-1896060-A | Tetrahydro-indolone and tetrahydro-indazolone derivatives and their use | GUOYAO LONGLI BIOLOG MEDICAL N (CN) | 2007-01-17 | — | — | CN | claimed |
| EP-1670314-A2 | METHODS AND COMPOSITIONS COMPRISING DIAMINES AS NEW ANTI-TUBERCULAR THERAPEUTICS | Sequella, Inc. (US) | 2006-06-21 | — | — | EP | claimed |
| WO-2006032994-A2 | MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2006-03-30 | — | — | WO | claimed |
| US-20050113574-A1 | Methods and compositions comprising diamines as new anti-tubercular therapeutics | SEQUELLA, INC. | 2005-05-26 | — | — | US | claimed |
| WO-2005034857-A2 | METHODS AND COMPOSITIONS COMPRISING DIAMINES AS NEW ANTI-TUBERCULAR THERAPEUTICS | SEQUELLA, INC. (US) | 2005-04-21 | — | — | WO | claimed |
| US-3951982-A | Trialkylsilyl esters of 6(substituted amino)phenyl-1,-dihydro-2-oxonicotinic acid, methods for their production and conversion to the corresponding acid chlorides | PARKE, DAVIS & COMPANY | 1976-04-20 | — | — | US | claimed |
| US-3946015-A | Process for the preparation of acid chlorides | PARKE, DAVIS & COMPANY (US) | 1976-03-23 | — | — | US | claimed |